ArticleBiomedicines2026
From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Pancreatic Cancer Models.
Kirill N Trachuk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.